A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Quantum Science to Exhibit at INFIQ® technology at Mobile World Congress 2023

Nanomaterials leader Quantum Science is preparing to showcase its INFIQ® quantum dot technology ahead of an exhibit at the world’s largest connectivity event.

Quantum Science is delighted to announce it has joined the UK trade mission for this year’s Mobile World Congress (MWC) exhibition in Barcelona.

The event, which runs from 27 February – 2 March at the Fira Gran Via, will see Quantum Science’s ground-breaking INFIQ® quantum dots displayed on a stand by the UK Government’s Department for International Trade (DIT).

Quantum Science will also feature in this year’s DIT UK Company Directory, which promotes innovative UK companies that have seen success on the international trading stage.

As well as appearing at the exhibit, Quantum Science’s leadership team will be in attendance, and is looking forward to meeting delegates and sharing the latest in high-performance quantum dot technology.

Dr Hao Pang, CEO and Founder of Quantum Science, said: “We’re really looking forward to attending MWC Barcelona this year and sharing the revolutionary science behind our INFIQ® quantum dots. This technology makes high-performance short-wave infrared sensing a reality and is already unlocking exciting new applications in consumer electronics markets, from smartphones sensors to car safety features. It’s set to be a great event and we can’t wait to see the other amazing technologies that will be on show!”

The MWC is an annual event that highlights the latest innovative technologies that will advance industries worldwide.

This year’s event will feature five key themes, focusing on 5G acceleration, Reality+, OpenNet, Digital Everything, and FinTech.

It is expected that more than 80,000 people will attend the conference from over 200 countries worldwide.

To arrange a meeting with the Quantum Science team at MWC23, contact info@qscis.com

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy